BlackRock Amends Adicet Bio Stake, Updates Passive Investment
Ticker: ACET · Form: SC 13G/A · Filed: Jan 31, 2024 · CIK: 1720580
| Field | Detail |
|---|---|
| Company | Adicet Bio, Inc. (ACET) |
| Form Type | SC 13G/A |
| Filed Date | Jan 31, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment, biotech
TL;DR
**BlackRock updated its Adicet Bio stock ownership, signaling a passive investment change.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 31, 2024, indicating a change in its ownership of Adicet Bio, Inc. Common Stock as of December 31, 2023. This filing, an amendment to a previous disclosure, shows BlackRock's updated passive investment position in the pharmaceutical company. For investors, this matters because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in confidence or strategy regarding Adicet Bio's future prospects.
Why It Matters
This filing updates BlackRock's passive ownership in Adicet Bio, providing transparency on a major institutional investor's position, which can influence market perception and trading decisions.
Risk Assessment
Risk Level: low — This filing is a routine update from a passive institutional investor and does not indicate any immediate high-risk events for Adicet Bio.
Analyst Insight
Investors should note BlackRock's continued passive interest in Adicet Bio, but this filing alone doesn't suggest a strong buy or sell signal. It's a routine update reflecting an institutional position.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Adicet Bio, Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 31, 2024 (date) — the date the SC 13G/A amendment was filed
- 007002108 (number) — the CUSIP number for Adicet Bio, Inc. Common Stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating a change in beneficial ownership by a passive investor.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., a major institutional investment manager.
What company's stock is the subject of this filing?
The subject company whose stock is being reported in this filing is Adicet Bio, Inc.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as stated in the filing.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 31, 2024 regarding Adicet Bio, Inc. (ACET).